When you think about glucagon-like peptide-1 receptor agonists (GLP-1 RAs), what comes to mind? Many will say weight loss. Others, type 2 diabetes care. But few will mention the influence these medications can have on menstrual cycles. 

So, can GLP-1 RAs affect your period? Some people see their cycle become more regular during treatment, but others experience disruptions. Let’s unpack what may be behind both experiences. 

Why do GLP-1 RAs cause menstrual changes?

Research on how GLP-1 RAs affect menstrual cycles in the broader population is pretty limited. Most studies zoom in on specific patient groups, such as women with polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS). Menstrual cycle irregularities are common among women with PMOS, and GLP-1 RAs present a possible solution. 

But the medical community recognizes that GLP-1 RAs may influence menstrual cycles more broadly, even for those without PMOS. For people who experience a positive change in their menstrual cycles, a few key drivers may play a role: 

• Insulin sensitivity: Insulin resistance happens when the hormone isn’t able to absorb enough sugar from your bloodstream. To gather up these extra sugars, your body produces more insulin. And according to The Menopause Society, too much insulin is associated with abnormal bleeding during menstrual cycles. GLP-1 RAs can help the body use insulin more efficiently to reduce this risk.
• Weight loss: People with obesity are twice as likely as those without obesity to have irregular menstrual cycles. While you’re taking GLP-1 RAs, you’re hungry less often and stay full longer after eating, helping you lose weight.
• Inflammation: A study from the American Journal of Obstetrics & Gynecology found that chronic inflammation might cause ovaries to struggle with releasing healthy eggs on time. GLP-1 RAs stop chemical messengers that cause inflammation from activating. This might contribute to more regular cycles, though more research is needed.

Keep in mind that some people have the opposite experience, with more painful and less regular periods on GLP-1 RAs. Rapid weight loss could contribute to this effect. Weight loss can make the brain think your body has less energy to spare, and to save energy, it could slow or stop reproductive signaling.

What to expect: Period changes on GLP-1 RAs 

Everyone’s body responds differently to treatment. You might notice changes in flow (whether heavier or lighter), delayed cycles, or spotting between cycles. Multiple contributing factors can shape these outcomes, from your lifestyle to baseline metabolic health. 

Your cycle also could normalize, or you may notice no change at all. Experiences vary widely, which is why care beyond the prescription matters. Choose a provider who will walk with you every step of the way. 

Also keep in mind that disrupted cycles during GLP-1 care are often temporary. Regular cycles can return as the body adjusts to treatment and weight loss and hormone levels stabilize. But tell your doctor if you notice any irregularities. They’ll rule out possible underlying causes.

GLP-1 RAs, PMOS, and fertility: What does the research say? 

PMOS is a hormone-related condition, previously known as polycystic ovary syndrome (PCOS). Approximately 85% of women with this condition have disrupted periods. Irregular cycles can make it more difficult to get pregnant because ovaries are releasing fewer eggs.

People struggling with their weight may also have a hard time conceiving. For every point BMI rises above 29, chances of getting pregnant drop by 5%. Since GLP-1 RAs help people lose weight, they can also boost fertility. 

Research also shows GLP-1 RAs regulate menstrual cycles. According to the Journal of Clinical Medicine, 71% of PMOS patients who lost 5% or more of their body weight on semaglutide saw their cycles normalize. More regular periods can improve your odds of conceiving. 

GLP-1 RAs and fertility: What are the safety considerations? 

GLP-1 RAs may support fertility, but they’re not recommended during pregnancy. There isn’t yet enough evidence to confirm their safety for fetal development. In most cases, doctors recommend discontinuing treatment about two months before conception. This allows enough time for it to clear the body. 

Fortunately, one small study found no increased risk of major birth defects or miscarriage with first trimester GLP-1 RA exposure. But early intervention is key. If you’re taking a GLP-1 RA and learn you’re pregnant (or are trying to conceive), let your doctor know. Together, you can make sure your care plan is right for this next chapter. 

The role of GLP-1 RAs in broader care plans 

GLP-1 RAs are just one part of a care plan to support menstrual cycles. Depending on your situation, your doctor may use multiple medications at once. For example, a 2026 study published in Metabolism and Target Organ Damage (M&TOD) brings another medication into the picture: metformin. 

This medication supports insulin sensitivity. The study found that 87% of women who took semaglutide alongside metformin saw their cycles normalize after 20 weeks, compared to 60% on metformin alone. This is just one example of combination therapy. Your doctor can assess your full health picture to build a plan tailored to your needs. 

When should you talk to a specialist about menstrual changes on a GLP-1 RA?

Raise any concerns you have about GLP-1 RAs and your reproductive health. Any changes you notice in your menstrual cycle warrant a conversation with your doctor (even changes that may seem insignificant). Also discuss potential pregnancy or any other symptoms that might be affecting you. You never know where your symptoms could be coming from, and it’s good to rule things out.

The symptoms you experience may be a normal part of your body adjusting to treatment. But still keep your doctor in the loop. They’ll rule out potential underlying causes and ensure your care plan remains on the right track. 

Access whole-person care with Maven Clinic

Irregular menstrual cycles can stem from hundreds of possible scenarios. At Maven Clinic, our specialists work with you to identify root causes and build care plans around what’s actually happening in your body. 

Maven Clinic takes a whole-person approach to women’s care. That’s why millions trust us. To find out more, read about our approach to GLP-1 care.

FAQ

Can semaglutide affect your period?

Yes, semaglutide can affect your period, but experiences vary. Some women see their menstrual cycles normalize, but irregular periods can occur, too. Any changes to your menstrual cycle (subtle or significant) warrant a conversation with your doctor. 

Can GLP-1 RAs cause hormonal imbalance?

Yes, in some cases. Multiple factors may lead to hormonal imbalances, including rapid weight loss and changes in dietary habits. These are often short-lived. Your doctor will monitor your progress and adjust treatment if needed. 

Does Ozempic® affect your period?

Ozempic® contains semaglutide as its active ingredient, which can influence menstrual cycles. Your doctor will walk you through which potential benefits and risks apply to you. 

What are Ozempic®’s side effects in women?

Common Ozempic® side effects include:

• Nausea
• Diarrhea
• Vomiting
• Abdominal pain
• Constipation

People commonly report these symptoms at the start of treatment or after dosage increases. They usually don’t last long, and your doctor can help you manage them. 

Are GLP-1 RAs safe?

For most people, GLP-1 RAs are safe when prescribed appropriately. Before you start treatment, your doctor will discuss any potential risks with you. 

Does tirzepatide affect your period?

Potentially. Tirzepatide is the active ingredient in brands such as Mounjaro® and Zepbound®. Similar to semaglutide, it may normalize menstrual cycles in some cases, but outcomes vary. 

Can weight loss pills affect your period?

It depends on multiple factors, from the medication type to individual responses. Wegovy® and (semaglutide) and Foundayo (Orforglipron)® are two FDA-approved pills for chronic weight management. They may support menstrual cycle normalization, but each person might see different results.